US Stock MarketDetailed Quotes

Medicus Pharma (MDCX)

Watchlist
  • 0.3513
  • +0.0510+16.98%
Close Apr 17 16:00 ET
  • 0.3265
  • -0.0248-7.06%
Post 19:58 ET
13.83MMarket Cap-0.13P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Medicus Pharma (MDCX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-122.27%-22.78M
-107.08%-6.61M
-117.85%-6.76M
-96.95%-5.47M
-234.85%-3.94M
-146.43%-10.25M
5.82%-3.19M
-1,987.82%-3.1M
-627.80%-2.78M
-391.30%-1.18M
Net income from continuing operations
-217.73%-35.44M
-131.43%-8.18M
-601.32%-15.98M
-70.01%-6.18M
-198.85%-5.1M
-109.90%-11.16M
-156.55%-3.54M
23.11%-2.28M
-643.42%-3.63M
-252.82%-1.71M
Operating gains losses
--66.95K
--33.13K
----
----
----
----
----
----
----
----
Depreciation and amortization
----
----
----
----
----
----
----
--26.32K
--26.04K
--26.04K
Other non cash items
6,383.51%10.52M
8,271.64%786.03K
30,191.65%9.37M
205.37%335.82K
-24.12%23.48K
-72.26%162.24K
99.10%-9.62K
-97.68%30.94K
-52.80%109.97K
-61.98%30.95K
Change In working capital
1,630.12%569.68K
138.33%626.57K
-56.46%-1.34M
58.01%253.99K
121.27%1.03M
-93.04%32.93K
125.20%262.9K
-157.76%-854.24K
227.75%160.74K
184.41%463.53K
-Change in prepaid assets
133.92%352.83K
103.28%35.3K
723.36%430.72K
-626.29%-235.84K
98.95%122.64K
-555.41%-1.04M
-521.11%-1.08M
-1,014.59%-69.1K
--44.81K
753.07%61.64K
-Change in payables and accrued expense
-59.87%458.77K
5.13%727.01K
-343.34%-1.72M
18.56%518.37K
131.56%930.59K
80.95%1.14M
179.52%691.52K
-126.32%-387.34K
447.46%437.21K
158.03%401.88K
-Change in other current liabilities
-103.50%-142.61K
-4.00%-36.44K
-1,006.36%-50.06K
29.65%-28.54K
---27.58K
---70.08K
---35.04K
--5.52K
---40.56K
--0
-Change in other working capital
---99.31K
----
----
----
----
----
----
---403.33K
----
----
Cash from discontinued investing activities
Operating cash flow
-122.27%-22.78M
-107.08%-6.61M
-117.85%-6.76M
-96.95%-5.47M
-234.85%-3.94M
-146.43%-10.25M
5.82%-3.19M
-1,987.82%-3.1M
-627.80%-2.78M
-391.30%-1.18M
Investing cash flow
Cash flow from continuing investing activities
-4.62M
0
0
0
Net business purchase and sale
---4.62M
--0
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
---4.62M
--0
----
----
----
--0
--0
----
----
----
Financing cash flow
Cash flow from continuing financing activities
151.65%31.94M
224.60%6.65M
10.37M
4.82%11.16M
3.76M
126.24%12.69M
2.05M
0
10.64M
0
Net issuance payments of debt
-13.48%4.48M
---1.62M
--1.65M
----
----
934.50%5.17M
--0
--0
----
----
Net common stock issuance
142.26%18.22M
62.48%3.33M
--5.1M
9.80%6.01M
--3.78M
--7.52M
--2.05M
--0
--5.47M
--0
Cash dividends paid
----
----
----
----
----
----
----
--0
----
----
Proceeds from stock option exercised by employees
--10.04M
--5.15M
--3.91M
----
----
--0
--0
--0
----
----
Net other financing activities
---790.23K
---205.87K
---286.58K
---272.78K
---25K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
151.65%31.94M
224.60%6.65M
--10.37M
4.82%11.16M
--3.76M
126.24%12.69M
--2.05M
--0
--10.64M
--0
Net cash flow
Beginning cash position
142.21%4.16M
63.25%8.66M
15.00%9.67M
634.22%3.98M
142.21%4.16M
542.38%1.72M
3.88%5.31M
5,636.53%8.41M
1,830.54%542.41K
542.38%1.72M
Current changes in cash
85.84%4.54M
103.88%44.36K
67.58%-1.01M
-27.70%5.69M
84.55%-181.89K
68.42%2.44M
66.30%-1.14M
-162.52%-3.1M
6,539.09%7.87M
-391.30%-1.18M
Effect of exchange rate changes
---2.97K
---1.23K
----
----
----
--0
--0
----
----
----
End cash Position
109.04%8.71M
109.04%8.71M
63.25%8.66M
15.00%9.67M
634.22%3.98M
142.21%4.16M
142.21%4.16M
3.88%5.31M
5,636.53%8.41M
1,830.54%542.41K
Free cash flow
-122.27%-22.78M
-107.08%-6.61M
-117.85%-6.76M
-96.95%-5.47M
-234.85%-3.94M
-146.43%-10.25M
5.82%-3.19M
-1,987.82%-3.1M
-627.80%-2.78M
-391.30%-1.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -122.27%-22.78M-107.08%-6.61M-117.85%-6.76M-96.95%-5.47M-234.85%-3.94M-146.43%-10.25M5.82%-3.19M-1,987.82%-3.1M-627.80%-2.78M-391.30%-1.18M
Net income from continuing operations -217.73%-35.44M-131.43%-8.18M-601.32%-15.98M-70.01%-6.18M-198.85%-5.1M-109.90%-11.16M-156.55%-3.54M23.11%-2.28M-643.42%-3.63M-252.82%-1.71M
Operating gains losses --66.95K--33.13K--------------------------------
Depreciation and amortization ------------------------------26.32K--26.04K--26.04K
Other non cash items 6,383.51%10.52M8,271.64%786.03K30,191.65%9.37M205.37%335.82K-24.12%23.48K-72.26%162.24K99.10%-9.62K-97.68%30.94K-52.80%109.97K-61.98%30.95K
Change In working capital 1,630.12%569.68K138.33%626.57K-56.46%-1.34M58.01%253.99K121.27%1.03M-93.04%32.93K125.20%262.9K-157.76%-854.24K227.75%160.74K184.41%463.53K
-Change in prepaid assets 133.92%352.83K103.28%35.3K723.36%430.72K-626.29%-235.84K98.95%122.64K-555.41%-1.04M-521.11%-1.08M-1,014.59%-69.1K--44.81K753.07%61.64K
-Change in payables and accrued expense -59.87%458.77K5.13%727.01K-343.34%-1.72M18.56%518.37K131.56%930.59K80.95%1.14M179.52%691.52K-126.32%-387.34K447.46%437.21K158.03%401.88K
-Change in other current liabilities -103.50%-142.61K-4.00%-36.44K-1,006.36%-50.06K29.65%-28.54K---27.58K---70.08K---35.04K--5.52K---40.56K--0
-Change in other working capital ---99.31K---------------------------403.33K--------
Cash from discontinued investing activities
Operating cash flow -122.27%-22.78M-107.08%-6.61M-117.85%-6.76M-96.95%-5.47M-234.85%-3.94M-146.43%-10.25M5.82%-3.19M-1,987.82%-3.1M-627.80%-2.78M-391.30%-1.18M
Investing cash flow
Cash flow from continuing investing activities -4.62M000
Net business purchase and sale ---4.62M--0--------------0--0------------
Cash from discontinued investing activities
Investing cash flow ---4.62M--0--------------0--0------------
Financing cash flow
Cash flow from continuing financing activities 151.65%31.94M224.60%6.65M10.37M4.82%11.16M3.76M126.24%12.69M2.05M010.64M0
Net issuance payments of debt -13.48%4.48M---1.62M--1.65M--------934.50%5.17M--0--0--------
Net common stock issuance 142.26%18.22M62.48%3.33M--5.1M9.80%6.01M--3.78M--7.52M--2.05M--0--5.47M--0
Cash dividends paid ------------------------------0--------
Proceeds from stock option exercised by employees --10.04M--5.15M--3.91M----------0--0--0--------
Net other financing activities ---790.23K---205.87K---286.58K---272.78K---25K--------------------
Cash from discontinued financing activities
Financing cash flow 151.65%31.94M224.60%6.65M--10.37M4.82%11.16M--3.76M126.24%12.69M--2.05M--0--10.64M--0
Net cash flow
Beginning cash position 142.21%4.16M63.25%8.66M15.00%9.67M634.22%3.98M142.21%4.16M542.38%1.72M3.88%5.31M5,636.53%8.41M1,830.54%542.41K542.38%1.72M
Current changes in cash 85.84%4.54M103.88%44.36K67.58%-1.01M-27.70%5.69M84.55%-181.89K68.42%2.44M66.30%-1.14M-162.52%-3.1M6,539.09%7.87M-391.30%-1.18M
Effect of exchange rate changes ---2.97K---1.23K--------------0--0------------
End cash Position 109.04%8.71M109.04%8.71M63.25%8.66M15.00%9.67M634.22%3.98M142.21%4.16M142.21%4.16M3.88%5.31M5,636.53%8.41M1,830.54%542.41K
Free cash flow -122.27%-22.78M-107.08%-6.61M-117.85%-6.76M-96.95%-5.47M-234.85%-3.94M-146.43%-10.25M5.82%-3.19M-1,987.82%-3.1M-627.80%-2.78M-391.30%-1.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -